UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

APASL consensus statements and recommendation on treatment of hepatitis C

Hepatology international, 2016-09, Vol.10 (5), p.702-726

2016

Volltextzugriff (PDF)

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Clinical and molecular hepatology, 2024-10, Vol.30 (4), p.1023

2024

Volltextzugriff (PDF)

Lymphoid Malignancies and Direct-Acting Antivirals: Review Article

The Egyptian journal of hospital medicine, 2022-10, Vol.89 (1), p.4540-4543

2022

Volltextzugriff (PDF)

Diversity of D-Amino Acid Utilizing Bacteria From Kongsfjorden, Arctic and the Metabolic Pathways for Seven D-Amino Acids

Frontiers in microbiology, 2020-01, Vol.10, p.2983-2983

2020

Volltextzugriff (PDF)

B-cell Clonality in HCV-Induced Patients Treated with Oral Direct-Acting Antiviral Agents

Asian Pacific Journal of Cancer Prevention, 2023-06, Vol.24 (6), p.2187-2193

2023

Volltextzugriff (PDF)

Renal transplantation using kidneys from hepatitis C-infected donors: A review of 30-years’ experience

Nefrología, 2023-03, Vol.43 (2), p.182-188

2023

Volltextzugriff (PDF)

EVALUATION OF THE SAFETY AND RESISTANCE ASSOCIATED VARIANTS OF SOFOSBUVIR/DACLATASVIR AMONG EGYPTIAN PATIENTS WITH HEPATITIS C VIRUS: A PROSPECTIVE STUDY

Bulletin of pharmaceutical sciences, 2022-12, Vol.45 (2), p.1143-1153

2022

Volltextzugriff (PDF)

Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”

Clinical and molecular hepatology, 2024-10, Vol.30 (4), p.1050

2024

Volltextzugriff (PDF)

Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project

Clinical infectious diseases, 2018-07, Vol.67 (3), p.460-463

2018

Volltextzugriff (PDF)

Correspondence on Letter regarding “Toward hepatitis C virus elimination using artificial intelligence”

Clinical and molecular hepatology, 2024-04, Vol.30 (2), p.274

2024

Volltextzugriff (PDF)

Pattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients

The Egyptian journal of hospital medicine, 2022-04, Vol.87 (1), p.2057-2063

2022

Volltextzugriff (PDF)

Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection

Internal Medicine, 2020, pp.3824-19

2020

Volltextzugriff (PDF)

Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis

Clinical gastroenterology and hepatology, 2019-08, Vol.17 (9), p.1840-1849.e16

2019

Volltextzugriff (PDF)

Recompensation of Chronic Hepatitis C–Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program

Gastroenterology (New York, N.Y. 1943), 2024-08

2024

Volltextzugriff (PDF)

DaaS: Towards Energy-Efficient Data Collection Optimization for Data as a Service in IoT networks

Procedia computer science, 2022, Vol.202, p.135-144

2022

Volltextzugriff (PDF)

Simultaneous Bilateral Total Hip Arthroplasty With Either the Direct Anterior or Posterior Approaches: A Propensity Score Match Study

The Journal of arthroplasty, 2024-08

2024

Volltextzugriff (PDF)

HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma

Journal of hepatology, 2018-01, Vol.68 (1), p.25-32

2018

Volltextzugriff (PDF)

Hepatitis C care cascade before and during the direct‐acting antiviral eras in New South Wales, Australia: A population‐based linkage study

Journal of viral hepatitis, 2023-03, Vol.30 (3), p.250-261

2023

Volltextzugriff (PDF)

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV

Gastroenterology (New York, N.Y. 1943), 2018-03, Vol.154 (4), p.989-997

2018

Volltextzugriff (PDF)

Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt

Virus research, 2023-01, Vol.323, p.198953-198953, Article 198953

2023

Volltextzugriff (PDF)

Drone as a Service (DaaS) in promoting cleaner agricultural production and Circular Economy for ethical Sustainable Supply Chain development

Journal of cleaner production, 2021-03, Vol.287, p.125522, Article 125522

2021

Volltextzugriff (PDF)

Meeting the challenges of hepatocellular carcinoma post sustained virologic response in the post-directacting antiviral era: A path forward: Editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Clinical and molecular hepatology, 2024-10, Vol.30 (4), p.677

2024

Volltextzugriff (PDF)

Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection

Journal of hepatology, 2020-07, Vol.73 (1), p.62-71

2020

Volltextzugriff (PDF)

Renal transplantation using kidneys from hepatitis C-infected donors: A review of 30-years’ experience

Nefrología, 2023-03, Vol.43 (2), p.182-188

2023

Volltextzugriff (PDF)

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience

Drug and alcohol dependence, 2020-01, Vol.206, p.107705-107705, Article 107705

2020

Volltextzugriff (PDF)

1 – 25 von 2.134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.564)
Mit Volltextzugriff
(1.731)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.259)
Life Sciences & Biomedicine
(1.055)
Daa
(668)
Humans
(631)
Hepatitis C
(546)
Hcv
(462)
Antiviral Agents - Therapeutic Use
(402)
Hepatitis C, Chronic - Drug Therapy
(346)
Daas
(340)
Hepatitis C Virus
(338)
Gastroenterology & Hepatology
(328)
Antiviral Agents
(317)
Hepatitis
(298)
Male
(283)
Female
(266)
Infectious Diseases
(247)
Middle Aged
(235)
Infections
(225)
Hepatitis C - Drug Therapy
(223)
Interferon
(216)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

APASL consensus statements and recommendation on treatment of hepatitis C

Lymphoid Malignancies and Direct-Acting Antivirals: Review Article

Diversity of D-Amino Acid Utilizing Bacteria From Kongsfjorden, Arctic and the Metabolic Pathways for Seven D-Amino Acids

B-cell Clonality in HCV-Induced Patients Treated with Oral Direct-Acting Antiviral Agents

Renal transplantation using kidneys from hepatitis C-infected donors: A review of 30-years’ experience

EVALUATION OF THE SAFETY AND RESISTANCE ASSOCIATED VARIANTS OF SOFOSBUVIR/DACLATASVIR AMONG EGYPTIAN PATIENTS WITH HEPATITIS C VIRUS: A PROSPECTIVE STUDY

Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”

Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project

Correspondence on Letter regarding “Toward hepatitis C virus elimination using artificial intelligence”

Pattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients

Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection

Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis

Recompensation of Chronic Hepatitis C–Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program

DaaS: Towards Energy-Efficient Data Collection Optimization for Data as a Service in IoT networks

Simultaneous Bilateral Total Hip Arthroplasty With Either the Direct Anterior or Posterior Approaches: A Propensity Score Match Study

HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma

Hepatitis C care cascade before and during the direct‐acting antiviral eras in New South Wales, Australia: A population‐based linkage study

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV

Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt

Drone as a Service (DaaS) in promoting cleaner agricultural production and Circular Economy for ethical Sustainable Supply Chain development

Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection

Renal transplantation using kidneys from hepatitis C-infected donors: A review of 30-years’ experience

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience

Suchergebnisse filtern